B-hTL1A/hDR3/hIL7R mice

C57BL/6-Tnfsf15tm2(TNFSF15)Bcgen Tnfrsf25tm3(TNFRSF25)Bcgen Il7rtm1(IL7R)Bcgen/Bcgen • 114152

B-hTL1A/hDR3/hIL7R mice

Product nameB-hTL1A/hDR3/hIL7R mice
Catalog number114152
Strain nameC57BL/6-Tnfsf15tm2(TNFSF15)Bcgen Tnfrsf25tm3(TNFRSF25)Bcgen Il7rtm1(IL7R)Bcgen/Bcgen
Strain backgroundC57BL/6
NCBI gene ID9966,8718,3575 (Human)
AliasesTL1; TL1A; VEGI; TNLG1B; VEGI192A; DR3; TR3; DDR3; LARD; APO-3; TRAMP; WSL-1; GEF720; WSL-LR; PLEKHG5; TNFRSF12; ILRA; CD127; IL7RA; CDW127; IMD104; sIL-7R; lnc-IL7R; IL7Ralpha; IL-7Ralpha; IL-7R-alpha

在此页面上

  • Description
  • Targeting strategy
  • Phenotypic analysis

海报

查看全部

    发表文章

      Description
      • TL1A binds to death receptor 3 (DR3) to provide stimulatory signals for downstream signaling pathways, thereby regulating the proliferation, activation, apoptosis of effector cells, and the production of cytokines and chemokines. Soluble decoy receptor 3 (DcR3) may neutralize the effects of soluble TL1A (sTL1A)/DR3. In addition, DcR3 can inhibit apoptosis, reduce inflammation, and prevent tissue damage by neutralizing LIGHT and FasL.
      • The IL-7 receptor alpha chain (IL-7Ra) and the common gamma chain (γc) serve as the components of the IL-7 receptor, undergoing dimerization upon binding with the IL-7 ligand. IL-7 and its receptor IL-7R are crucial for the normal development, differentiation, and survival of T cells and B cells. Abnormal IL-7/IL-7R signaling is believed to be associated with the pathogenesis of various autoimmune or inflammatory diseases.
      • The genome of the mouse Tl1a gene encoding the extracellular domain was replaced with human TL1A counterpart in B-hTL1A/hDR3/hIL7R mice. The genome of the mouse DR3 gene encoding the full-length protein was replaced with human DR3 counterpart in B-hTL1A/hDR3/hIL7R mice. The genome of the mouse Il7r gene encoding the extracellular domain was replaced with human IL7R counterpart in B-hTL1A/hDR3/hIL7R mice.
      • Human TL1A, DR3, IL7R protein were exclusively detectable in homozygous B-hTL1A/hDR3/hIL7R mice.
      • This product is used for the evaluation of the pharmacodynamics and safety of anti-human TL1A/DR3/IL7R antibodies in autoimmune diseases such as inflammatory bowel disease.
      Targeting strategy

      Gene targeting strategy for B-hTL1A/hDR3/hIL7R mice.

      The exons 1-4 of mouse Tl1a gene that encode extracellular domain were replaced by human counterparts in B-hTL1A/hDR3/hIL7R mice. The genomic region of mouse Tl1a gene that encodes transmembrane domain and cytoplasmic portion was retained. The promoter, 5’UTR and 3’UTR region of the mouse gene were also retained. The human TL1A expression was driven by endogenous mouse Tl1a promoter, while mouse Tl1a gene transcription and translation will be disrupted.

      The exons 1-10 of mouse DR3 gene that encode the whole molecule (ATG to STOP codon), including promoter, 5’UTR and 3’UTR were replaced by human counterparts in B-hTL1A/hDR3/hIL7R mice. The human DR3 expression was driven by human DR3 promoter, while mouse DR3 gene transcription and translation will be disrupted.

      The exons 1-6 of mouse Il7r gene that encode the extracellular region were replaced by human IL7R exons 1-6 in B-hTL1A/hDR3/hIL7R mice.

      Note: B-hTL1A/hDR3/hIL7R mice were obtained by mating B-hTL1A/hDR3 mice (113082) and B-hIL7R mice (110082).

      Protein expression analysis

      Soluble TL1A expression analysis in B-hTL1A/hDR3/hIL7R mice by ELISA. Bone marrow derived dendritic cells (BMDCs) were produced by culturing the bone marrow from wild-type C57BL/6JNifdc mice (+/+), and B-hTL1A/hDR3/hIL7R mice (H/H;H/H;H/H), which were stimulated with1 μg/mL LPS in vitro for 24 hrs. After stimulation, the supernatants were collected and the levels of soluble TL1A were measured using a species-specific human TL1A ELISA kit (R&D, DY1319-05). Soluble human TL1A was exclusively detectable in homozygous B-hTL1A/hDR3/hIL7R mice. Values are expressed as mean ± SEM. ND: not detectable.

      Strain specific DR3 expression analysis in homozygous B-hTL1A/hDR3/hIL7R mice by flow cytometry. Splenocytes were collected from wild-type C57BL/6JNifdc (+/+) and homozygous B-hTL1A/hDR3/hIL7R mice (H/H;H/H;H/H) stimulated with anti-mouse CD3ε antibody and anti-mouse CD28 antibody in vivo for 24 h, protein expression was analyzed by flow cytometry with species-specific anti-mouse DR3 antibody (BioLegend, 144407) and anti-human DR3 antibody (Biolegend, 307105). Mouse DR3 was detectable on CD4+ T cells of wild-type C57BL/6JNifdc mice. Human DR3 was detectable on CD4+ T cells of homozygous B-hTL1A/hDR3/hIL7R mice.

      Strain specific IL7R expression analysis in homozygous B-hTL1A/hDR3/hIL7R mice by flow cytometry. Splenocytes were collected from wild-type C57BL/6JNifdc mice (+/+) and homozygous B-hTL1A/hDR3/hIL7R mice (H/H;H/H;H/H), protein expression was analyzed by flow cytometry with species-specific anti-mouse IL7R antibody (Biolegend, 135011) and anti-human IL7R antibody (Biolegend, 351303). Mouse IL7R was detectable in wild-type C57BL/6JNifdc mice. Human IL7R was detectable in homozygous B-hTL1A/hDR3/hIL7R mice.

      * When publishing results obtained using this animal model, please acknowledge the source as follows: The animal model [B-hTL1A/hDR3/hIL7R mice] (Cat# 114152) was purchased from Biocytogen.